|
|
|
|
||
|
||
|
Vol. 8, Nos. 1-50, pp. 1-1650 Jan. 1 -- Dec. 31, 2010 # | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Aaron v. SmithKlineBeecham Corp. (S.D. Ill.), 626
Aaron v. Wyeth (W.D. Pa.), 277 Abbott Labs. v. Apotex Inc. (D. Del.), 36 Abbott Labs. v. Apotex Inc. (N.D. Ill.), 977 Abbott Labs.; Centocor Inc. v. (E.D. Tex.), 6 Abbott Labs.; Ethypharm S.A. France v. (D. Del.), 1506 Abbott Labs.; Florida v. (D. Del.), 59 Abbott Labs.; Iowa v. (D. Mass.), 1465 Abbott Labs.; Louisiana v. (La. Dist. Ct.), 1430 Abbott Labs.; New York, City of v. (D. Mass.), 1465 Abbott Labs.; Safeway Inc. v. (N.D. Cal.), 126 Abbott Labs.; U.S. ex rel. Carpenter v. (D. Mass.), 943 Abbott Labs. v. U.S. Dist. Court for the N. Dist. of Cal. (9th Cir.), 1246 Abbott Labs. v. Watson Pharms. Inc. (D. Del.), 623 Abbott Labs.; Wisconsin v. (Wis. Cir. Ct.), 553 Abbott Labs. Norvir Antitrust Litig., In re (N.D. Cal.), 781 Abdullahi; Pfizer Inc. v. (U.S., brief filed), 719; (rev den), 852; (S.D.N.Y.), 1345 Abitang Actavis Elizabeth LLC; Eli Lilly & Co. v. (D.N.J.), 33; 1079; (Fed. Cir.), 1135; 1157 Actavis Elizabeth LLC v. FDA (D.C. Cir.), 1425 Actavis Elizabeth LLC v. Johnson (D.D.C.), 311 Actavis Elizabeth LLC v. Mensing (U.S., rev sought), 677; (brief filed), 1428; (rev grant), 1577 Actavis Inc.; Demahy v. (5th Cir.), 85; (U.S., brief filed), 1086; (rev grant), 1577 Actavis Totowa LLC; Yarbrough v. (S.D. Ga.), 1221 Actimmune Mktg. Litig., In re (N.D. Cal.), 1182 Action Alliance of Senior Citizens v. Sebelius (D.C. Cir.), 815 Adams v. I-Flow Corp. (C.D. Cal.), 488 Adams v. Wyeth (D.P.R.), 1556 Adams Labs. Inc.; Ranes v. (Iowa), 235 Adams Respiratory Therapeutics Inc. v. Perrigo Co. (W.D. Mich.), 200; (Fed. Cir.), 1051 Adamu v. Pfizer Inc. (S.D.N.Y.), 1345 AIDS Healthcare Found. v. Bristol-Myers Squibb Co. (C.D. Cal.), 1502 AIDS Healthcare Found. v. Tibotec Therapeutics (C.D. Cal.), 1621 Alabama; AstraZeneca Pharms. LP v. (Ala.), 127 Alaska Elec. Pension Fund; Pharmacia Corp. v. (U.S., rev den), 589 Albany Molecular Research Inc. v. Dr. Reddy's Labs. Ltd. (D.N.J.), 744; 773 Alcon Labs. Inc.; RxUSA Wholesale Inc. v. (2d Cir.), 1141 Alcon Labs. Inc. v. Teva Pharms. USA Inc. (D. Del.), 1053 Alcon S'holder Litig., In re (S.D.N.Y.), 920 Alfuzosin Hydrochloride Patent Litig., In re (D. Del.), 642; 1106 Allergan Inc.; Helton v. (Okla. Dist. Ct.), 682 Allergan Inc.; Kramer v. (Cal. Super. Ct.), 322 Allergan Inc.; Ocular Research of Boston Inc. v. (E.D. Tex.), 747 Allergan Inc. v. Sandoz Inc. (E.D. Tex.), 35 Allergan Inc. v. U.S. (D.D.C.), 87; 519 Allergan Inc.; U.S. v. (N.D. Ga.), 1131 Allergan Inc.; U.S. ex rel. Beilfuss v. (N.D. Ga.), 1131 Allergan Inc.; U.S. ex rel. Hallivis v. (N.D. Ga.), 1131 Allergan Inc.; U.S. ex rel. Lang v. (N.D. Ga.), 1131 Allergan Inc. v. Watson Pharms. Inc. (E.D. Tex.), 1142 Alpharma Inc. v. Purdue Pharma LP (W.D. Va.), 987 Alpharma Inc.; State v. (Idaho Dist. Ct.), 1341 Alpharma Inc.; U.S. ex rel. Parks v. (D. Md.), 352 Alpharma USPD Inc.; Idaho v. (Idaho Dist. Ct.), 714 Altana Pharma AG v. Teva Pharms. USA Inc. (D.N.J.), 584; 941; 1105 Alza Corp. v. Andrx Pharms. LLC (Fed. Cir.), 549 Alza Corp. v. Impax Labs. Inc. (D. Del.), 1504 Alza Corp. v. Thompson (Tex. Ct. App.), 457 Alza Corp.; Winters v. (S.D.N.Y.), 237 Amalong v. Wyeth Pharms. Inc. (D. Minn.), 1433 American Sales Co. v. Novo Nordisk A/S (E.D. Mich.), 715 American Sales Co. v. SmithKlineBeecham Corp. (E.D. Pa.), 1464 Amgen Inc. v. F. Hoffmann-LaRoche Ltd. (D. Mass.), 5 Amgen Inc.; Teva Pharms. USA Inc. v. (E.D. Pa.), 1498 Amgen Inc.; United Food and Commercial Workers Cen. Pa. & Reg'l Health & Welfare Fund v. (9th Cir.), 1363 Amgen Inc.; U.S. ex rel. Westmoreland v. (D. Mass.), 581; 1275 Amgen Inc.; Warren Gen. Hosp. v. (D.N.J.), 782 Amneal Pharms. LLC; Fresenius Med. Care Holdings Inc. v. (D. Mass.), 1145 Amneal Pharms. LLC; Ortho-McNeil-Janssen Pharms. Inc. v. (D.N.J.), 747 Amphastar Pharms. Inc. v. FDA (D.D.C.), 1396; 1459 Anchen Pharms. Inc.; Elan Pharma Intl. Ltd. v. (C.D. Cal.), 1141 Anchen Pharms. Inc.; Elan Pharma Intl. Ltd. v. (D. Del.), 1141 Anderson v. Bayer Corp. (7th Cir.), 888 Andrews v. Bayer Corp. (N.D. Cal.), 131 Androgel Antitrust Litig. (No. II), In re (N.D. Ga.), 229; 1211 Andrx Pharms. LLC; Alza Corp. v. (Fed. Cir.), 549 Apotex v. Minister of Health (Canada, Fed. Ct. App.), 1638 Apotex Corp.; Astra Zeneca AB v. (In re Omeprazole Patent Litig.) (S.D.N.Y.), 811 Apotex Corp.; Cephalon Inc. v. (D. Del.), 1107 Apotex Inc.; Abbott Labs. v. (D. Del.), 36 Apotex Inc.; Abbott Labs. v. (N.D. Ill.), 977 Apotex Inc.; AstraZeneca Pharms. LP v. (D. Del.), 1610 Apotex Inc.; AstraZeneca Pharms. LP v. (Fed. Cir.), 1391 Apotex Inc.; Colacicco v. (E.D. Pa.), 11 Apotex Inc.; Daiichi Sankyo Co. v. (D. Del.), 1053 Apotex Inc. v. Eisai Inc. (M.D.N.C.), 1140 Apotex Inc.; Eli Lilly & Co. v. (Canada, Fed. Ct. App.), 1327 Apotex Inc.; Eli Lilly Canada Inc. v. (Canada, Fed. Ct.), 1477 Apotex Inc. v. H. Lundbeck A/S (Canada, Fed. Ct.), 1235 Apotex Inc.; Hoffmann-LaRoche Inc. v. (D.N.J.), 1137 Apotex Inc. v. Merck & Co. (Canada, Fed. Ct.), 502 Apotex Inc.; Pfizer Inc. v. (D. Del.), 181 Apotex Inc.; Pfizer Inc. v. (N.D. Ill.), 181; 1085 Apotex Inc. v. Pfizer Ireland Pharms. (Canada, Fed. Ct.), 830 Apotex Inc.; Sanofi-Synthelabo v. (S.D.N.Y.), 514; 1339 Apotex Inc. v. Sebelius (D.D.C.), 414; (D.C. Cir.), 451; 644; 885; (U.S., rev sought), 1301 Apotex Inc.; Senju Pharm. Co. v. (D. Del.), 851 Apotex Inc.; Utah v. (Utah Dist. Ct.), 271 APP Pharms. LLC; Stanger v. (D.N.J.), 1556 Ariad Pharms. Inc. v. Eli Lilly & Co. (Fed. Cir.), 381 Arius Two Inc. v. Kappos (D.D.C.), 233 Arkansas Carpenters Health and Welfare Fund v. Bayer AG (2d Cir.), 675; 853; 1130 Arnett v. Mylan Inc. (S.D.W. Va.), 718 Astellas Pharma Inc. v. Lupin Ltd. (U.S., rev den), 59 Astra USA Inc.; Santa Clara, County of v. (9th Cir.), 34; (U.S., rev grant), 1243; (amicus brief filed), 1618 Astra Zeneca AB v. Apotex Corp. (In re Omeprazole Patent Litig.) (S.D.N.Y.), 811 AstraZeneca AB v. Dr. Reddy's Labs. Ltd. (D.N.J.), 1431 AstraZeneca AB v. Dr. Reddy's Labs. Ltd. (Fed. Cir.), 5 AstraZeneca AB v. Ivax Corp. (D.N.J.), 59 AstraZeneca Canada Inc. v. Novopharm Ltd. (Canada, Fed. Ct. App.), 604 AstraZeneca Pharms. LP v. Alabama (Ala.), 127 AstraZeneca Pharms. LP v. Apotex Inc. (D. Del.), 1610 AstraZeneca Pharms. LP v. Apotex Inc. (Fed. Cir.), 1391 AstraZeneca Pharms. LP; Baker v. (N.J. Super. Ct.), 387 AstraZeneca Pharms. LP v. Barr Labs. Inc. (D. Del.), 643 AstraZeneca Pharms. LP v. Blue Cross Blue Shield of Mass. (U.S., dism), 1272 AstraZeneca Pharms. LP; Burrell v. (Del. Super. Ct.), 1249 AstraZeneca Pharms. LP; Flowers v. (Del. Super. Ct.), 1249 AstraZeneca Pharms. LP; Guinn v. (11th Cir.), 521 AstraZeneca Pharms. LP; Hood ex rel. Mississippi v. (N.D. Miss.), 1343 AstraZeneca Pharms. LP v. Mylan Pharms. Inc. (D. Del.), 643 AstraZeneca Pharms. LP; Ro v. (Del. Super. Ct.), 1249 AstraZeneca Pharms. LP; Teva Pharm. Indus. Ltd. v. (E.D. Pa.), 1461 AstraZeneca Pharms. LP v. Torrent Pharms. Ltd. (D. Del.), 919 AstraZeneca UK Ltd. v. Dr. Reddy's Labs. Ltd. (D.N.J.), 1497 Attorney Gen. of Canada; Bayer Schering v. (Canada, Fed. Ct. App.), 1417 Attorney Gen. of Canada v. Celgene Corp. (Canada, Fed. Ct. App.), 533; (Canada), 570 Aurobindo Pharma Ltd.; Takeda Pharms. Co. v. (S.D.N.Y.), 644 Austin, U.S. ex rel. v. Novartis Pharms. Corp. (M.D. Fla.), 1269 Aventis Pharma SA v. Hospira Inc. (D. Del.), 1245 Axonyx Sec. Litig., In re (2d Cir.), 419 Contact the Webmaster at webmaster@bna.com Copyright © The Bureau of National Affairs, Inc. All Rights Reserved. |
